These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
180 related items for PubMed ID: 7755110
1. Patient response and resource management: another view of clozapine treatment of schizophrenia. Carpenter WT, Conley RR, Buchanan RW, Breier A, Tamminga CA. Am J Psychiatry; 1995 Jun; 152(6):827-32. PubMed ID: 7755110 [Abstract] [Full Text] [Related]
3. [Clozapine and treatment of negative symptoms]. Lançon C, Farisse J, Llorca PM. Encephale; 1997 Sep; 23 Spec No 4():7-11. PubMed ID: 9417403 [Abstract] [Full Text] [Related]
4. A double-blind comparative study of clozapine and risperidone in the management of severe chronic schizophrenia. Azorin JM, Spiegel R, Remington G, Vanelle JM, Péré JJ, Giguere M, Bourdeix I. Am J Psychiatry; 2001 Aug; 158(8):1305-13. PubMed ID: 11481167 [Abstract] [Full Text] [Related]
5. Treatment-resistant schizophrenia--the role of clozapine. Meltzer HY. Curr Med Res Opin; 1997 Aug; 14(1):1-20. PubMed ID: 9524789 [Abstract] [Full Text] [Related]
7. Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials. Chakos M, Lieberman J, Hoffman E, Bradford D, Sheitman B. Am J Psychiatry; 2001 Apr; 158(4):518-26. PubMed ID: 11282684 [Abstract] [Full Text] [Related]
8. The pharmacoeconomics of clozapine: a review. Meltzer HY, Cola PA. J Clin Psychiatry; 1994 Sep; 55 Suppl B():161-5. PubMed ID: 7961564 [Abstract] [Full Text] [Related]
9. A randomized trial comparing clozapine and typical neuroleptic drugs in non-treatment-resistant schizophrenia. Meltzer HY, Bobo WV, Lee MA, Cola P, Jayathilake K. Psychiatry Res; 2010 May 30; 177(3):286-93. PubMed ID: 20378185 [Abstract] [Full Text] [Related]
10. [Leponex, 10 years after -- a clinical review]. Llorca PM, Pere JJ. Encephale; 2004 May 30; 30(5):474-91. PubMed ID: 15627052 [Abstract] [Full Text] [Related]
11. [Medico-economic evaluation of treatment with clozapine versus treatment with previous neuroleptics]. Geronimi-Ferret D, Lesay M, Barges-Bertocchio MH, Cornet-Bonnefont M, Robert H. Encephale; 1997 Sep 30; 23 Spec No 4():24-31. PubMed ID: 9417402 [Abstract] [Full Text] [Related]
13. Clozapine for treatment-resistant schizophrenia: National Institute of Clinical Excellence (NICE) guidance in the real world. Mortimer AM, Singh P, Shepherd CJ, Puthiryackal J. Clin Schizophr Relat Psychoses; 2010 Apr 30; 4(1):49-55. PubMed ID: 20643629 [Abstract] [Full Text] [Related]
14. Clinical effects of clozapine in chronic schizophrenia: response to treatment and predictors of outcome. Lieberman JA, Safferman AZ, Pollack S, Szymanski S, Johns C, Howard A, Kronig M, Bookstein P, Kane JM. Am J Psychiatry; 1994 Dec 30; 151(12):1744-52. PubMed ID: 7977880 [Abstract] [Full Text] [Related]
15. Where to position clozapine: re-examining the evidence. Agid O, Foussias G, Singh S, Remington G. Can J Psychiatry; 2010 Oct 30; 55(10):677-84. PubMed ID: 20964947 [Abstract] [Full Text] [Related]
16. Multiple outcome assessment in a study of the cost-effectiveness of clozapine in the treatment of refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia. Rosenheck R, Cramer J, Xu W, Grabowski J, Douyon R, Thomas J, Henderson W, Charney D. Health Serv Res; 1998 Dec 30; 33(5 Pt 1):1237-61. PubMed ID: 9865219 [Abstract] [Full Text] [Related]
17. Management of treatment-resistant patients with schizophrenia. Marder SR. J Clin Psychiatry; 1996 Dec 30; 57 Suppl 11():26-30. PubMed ID: 8941168 [Abstract] [Full Text] [Related]
18. Idazoxan and response to typical neuroleptics in treatment-resistant schizophrenia. Comparison with the atypical neuroleptic, clozapine. Litman RE, Su TP, Potter WZ, Hong WW, Pickar D. Br J Psychiatry; 1996 May 30; 168(5):571-9. PubMed ID: 8733795 [Abstract] [Full Text] [Related]